Early use of long‐acting injectable antipsychotics in bipolar disorder type I: An expert consensus

Eduard Vieta; Mauricio Tohen; Diane McIntosh; Lars Vedel Kessing; Martha Sajatovic; Roger S. McIntyre

doi:10.1111/bdi.13498

Abstract

1 min read

This review discusses the benefits of LAIs in the management of BP-I and identifies barriers to use, while providing expert consensus recommendations for potential solutions to support informed treatment decision-making.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

The Role of Long Acting Antipsychotics in Bipolar Disorder

Eduard Vieta

Article2004

Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology

José López‐Sendón, Karl Swedberg, John J.V. McMurray, Juan Tamargo, Aldo Maggioni, Henry Dargie, Michał Tendera, Finn Waagstein, J Kjekshus, Philippe Lechat, Christian Torp‐Pedersen

Article2004

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular diseaseThe Task Force on ACE-inhibitors of the European Society of Cardiology

José López‐Sendón, Karl Swedberg, John J.V. McMurray, Juan Tamargo, Aldo Maggioni, Henry Dargie, Michał Tendera, Finn Waagstein, J Kjekshus, Philippe Lechat, Christian Torp‐Pedersen

Article2016

Detection and management of agitation in psychiatry: A Delphi expert consensus study

Marina Garriga, Isabella Pacchiarotti, Diego Hidalgo, Miquel Bernardo, Eduard Vieta

Article2023

Implementing well‐being in the management of psoriasis: An expert recommendation

Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn du Jardin, Ismail Kasujee, Elisa Martini, E. Daudén, Gabriella Fabbrocini, Alexander Zink, Christopher Em Griffiths, Matthias Augustin